Kardigan, Inc. Common Stock (KARD) News

Latest headlines that mention KARD, newest first · each headline opens the original publisher

KARD quote
Last price
$12.66
Day change
+2.76%
Next earnings
—

KARD headlines

latest coverage
TheStreet
Kardigan (KARD) didn’t just raise $400 million. The heart-drug developer sent a new signal to biotech investors about what Wall Street is willing to fund in 2026. That is not a simple optimism. It’s prejudiced. Biotech businesses might toss around early research, big potential…
General T3KARD

KARD news alerts

Get an alert by email or push when a new headline mentions KARD.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.